Coagulation Factor X Inhibitor Screen, Plasma
Factor X is a member of the common coagulation pathway, in conjunction with Factor V and Calcium, that converts prothrombin into thrombin, which in turn converts fibrinogen to fibrin. Coagulation tests to assess the activity of the common pathway usually include the thrombin time test and a fibrinogen assay. Factor X disorders will usually prolong the Prothrombin Time, Activated Partial Thromboplastin time, and the Russell’s Viper Venom Time Test. It also correlates by being corrected upon mixing studies. Inherited Factor X deficiency is possible; however, it is extremely rare. The occurrence is 1 per 500,000. Notable deficiency can happen at any age and the severest of symptoms pertain to the very young. For most individuals a level of 10% (as compared to a normal individual with 100%) is adequate for hemostasis. Treatment for deficiency consists of fresh frozen plasma therapy or prothrombin-complex concentrates.
Clinical symptoms of deficiency range from easy bruising in mild cases to postoperative hemorrhage in very severe cases. Family history and clinical data are useful indicators in differentiating inherited verses acquired deficiency. Other factors to assess are liver disease and vitamin K deficiency. Factor X deficiency has been noted in amyloidosis and also due to variant forms of Factor X because of amino acid substitution or deletions.
- Diagnosis of congenital or acquired coagulation factor X deficiency
- To evaluate hemostatic function in liver disease
- Assessment of a prolonged PT and aPTT
Decreased in:
- Bruising
- Epitaxis
- Gastrointestinal Bleeding
- Menorrhagia
- Prolonged PT and aPTT
- Poor Diet
- Oral Anticoagulants
60 - 150 %
Plasma Citrate (Blue Top)
Stability
- Ambient: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 60 days
- Separate Plasma and freeze immediately. Maintain frozen until testing.
- Kessler C. Hemorrhagic disorders: Coagulation factor deficiencies. In: Goldman L, Ausiello D (eds.) Cecil Medicine. 23rd ed. Philadelphia, Pa:Saunders Elsevier (2007). Ch. 180.
- Harmening D. Clinical Hematology and Fundamentals of Hemostasis. Philadelphia: F. A. Davis Company (1997).
- Gailani D and Neff AT. Rare coagulation factor deficiencies. In: Hoffman R, Benz EJ Jr., Shattil SJ, et al (eds.) Hoffman Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Churchill Livingstone Elsevier (2008). Ch. 127.